Science TLDR

**Top Trending Friday** — our weekly pick of the top-trending paper on r/science this week. **Paper:** [Probability of a timely vocal response in mother-infant interaction and later psychiatric diagnosis: A case-control study](https://doi.org/10.1371/journal.pone.0344552) **Authors:** Bethany Stanley, Clare S. Allely, Jenna Charlton, Christopher Gillberg, et al. **Journal:** PLOS One, 2024 **Why it matters:** A single timing metric — whether a mother vocalizes back within one second — independently predicts her child's risk of ADHD or disruptive behavior disorder at age seven, suggesting that the rhythmic architecture of early caregiver–infant interaction may be a useful, objective clinical marker. --- **Summary** This case-control study asks whether the timing of vocal exchanges between mothers and 12-month-old infants — measured as the probability of responding within a defined window — predicts later psychiatric diagnosis. The researchers drew on the Avon Longitudinal Study of Parents and Children (ALSPAC), a UK population cohort enrolling pregnant women in the early 1990s, and analyzed VHS video recordings of 158 mother-infant dyads interacting over a picture book in a clinic setting. At age seven, those same children were assessed using the Development and Wellbeing Assessment (DAWBA), a structured tool that synthesizes parent and teacher reports to generate DSM-IV psychiatric classifications. The final sample comprised 103 neurotypical controls and 55 cases spanning disruptive behavior disorders (DBD), ADHD, autism spectrum (pervasive developmental disorder), and emotional disorders. To identify optimal response thresholds, the team used survival analysis — specifically Kaplan-Meier curves — to map the distribution of silence duration following each vocalization across a sliding 0.5–10 second window. The most statistically stable thresholds emerged at one second for maternal responses and eight seconds for infant responses, reflecting the large gap in cognitive and motor processing speed between a fully developed adult and a one-year-old. Predictive modeling then used Firth's penalized logistic regression, a method that corrects for bias from small subgroup sizes, to test whether these timing probabilities forecast diagnosis six-and-a-half years later. Only the maternal measure proved predictive. After adjusting for maternal age, birth weight, maternal depression, and socioeconomic status, a 10% increase in the probability of the mother responding within one second was associated with a 17% decrease in the odds of any psychiatric diagnosis — an effect concentrated in ADHD and DBD. Neither timing metric predicted autism spectrum or emotional disorders, though the autism subgroup contained only six children, making the null result essentially uninterpretable due to insufficient statistical power. A key limitation across all findings is that degraded 1990s audio prevented any analysis of speech content, pitch, or motherese — so every vocalization was coded as a binary event regardless of its emotional quality. --- **Three takeaways** 1. A 10% increase in the probability of a maternal vocal response within one second was associated with a 17% reduction in the odds of any psychiatric diagnosis at age seven, an effect that survived adjustment for maternal depression, socioeconomic status, birth weight, and maternal age. 2. The predictive signal was specific to ADHD and disruptive behavior disorders; neither maternal nor infant timing metrics predicted pervasive developmental disorder or emotional disorders in this cohort. 3. The infant's eight-second response probability carried essentially no predictive weight for later psychiatric outcomes — the diagnostic information resided entirely on the caregiver side of the interaction. --- **Read the source:** https://doi.org/10.1371/journal.pone.0344552

**Monday Immune Engager** — our weekly pick from the latest immune-engager digest. **Paper:** [Covalently PD‐L1 Anchoring Drives Bispecific Nanostructure Assembly for Spatial Control of T Cell Recruitment and Activation](https://doi.org/10.1002/anie.5894316) **Authors:** Fengzhen Zhang, Yuhan Dong, Kailu Liu, Hui Hu, et al. **Journal:** Angewandte Chemie International Edition, 2025 **Why it matters:** Rather than passively blocking tumor immune checkpoints, this work shows it is possible to chemically hijack a tumor's own surface machinery to build synthetic nanostructures that simultaneously relieve immune suppression and actively recruit and activate T cells. **Summary** Current immune checkpoint therapies that block the PD-1/PD-L1 axis — the suppressive signaling pathway tumors use to exhaust T cells — benefit only around 20% of patients. Blocking the pathway removes an inhibitory signal but does not actively stimulate T cells to attack, a distinction the authors liken to releasing a parking brake without pressing the accelerator. This paper introduces a two-step "localized oxidation–covalent assembly" strategy designed to do both at once. The first component, the P1 probe, is a conjugate of a PD-L1-targeting peptide (Kd ≈ 4.5 µM) and the enzyme galactose oxidase (GAO). Once the probe transiently binds PD-L1, GAO oxidizes the C6 hydroxyl groups on PD-L1's N-linked glycans, converting them to aldehydes. Specificity was confirmed using a glycosylation-deficient PD-L1 mutant (4NQ) and the inhibitor tunicamycin, both of which sharply reduced oxidation. These aldehyde groups serve as covalent anchors for the second component: a hydrazide-functionalized self-assembling peptide (HSP) incorporating an anti-CD3 sequence. Covalent attachment of HSP to the oxidized membrane dramatically lowers its critical aggregation concentration (CAC) from 38.26 µM to 2.18 µM, driving rapid β-sheet and π–π stacking assembly into stable artificial topological nanostructures (ATNs) directly on the tumor surface. The resulting ATNs act as membrane-anchored bispecific T cell engagers (BiTEs): they block PD-1/PD-L1 interaction while projecting anti-CD3 sequences outward to recruit and activate passing T cells. In vivo in MC38 tumor-bearing mice, this achieved 62.6% tumor inhibition, with increased intratumoral PD-1⁺ T cells and interferon-γ secretion. Efficacy also translated to patient-derived lung cancer organoids. A key limitation the authors acknowledge is the potential for off-target glycan oxidation by the GAO enzyme in a systemic context, which will require tumor-microenvironment-responsive activation strategies in future iterations. **Three takeaways** 1. Covalent anchoring via PD-L1 glycan oxidation drops the peptide CAC nearly 18-fold (38.26 µM → 2.18 µM), triggering localized self-assembly of ATNs specifically on PD-L1-overexpressing tumor cells rather than on bystander tissue. 2. ATN-treated co-cultures showed 2.61-fold higher tumor cell killing versus non-assembling controls, alongside a doubling of interferon-γ secretion and a peak in CD69 expression at ~8 hours — demonstrating genuine T cell activation rather than mere recruitment. 3. The covalent assembly strategy significantly outperformed a non-covalent analogue under mildly acidic, physiologically dynamic conditions, and this stability advantage translated to 62.6% tumor volume inhibition in vivo and efficacy in patient-derived lung cancer organoids. **Read the source:** https://doi.org/10.1002/anie.5894316

**Top Trending Friday** — our weekly pick of the top-trending paper on r/science this week. **Paper:** [Work from Home and Disability Employment](https://doi.org/10.1257/aeri.20240538) **Authors:** Nicholas Bloom, Gordon B. Dahl, Dan-Olof Rooth **Journal:** American Economic Review: Insights, 2025 **Why it matters:** The post-pandemic rise in remote work appears to have accomplished more for disability employment than three decades of targeted legal mandates ever did. **Summary** Between 2019 and 2024, full-time employment for working-age adults with physical disabilities surged roughly 14% — an unprecedented divergence from employment trends for non-disabled workers, which remained essentially flat over the same period. Bloom, Dahl, and Rooth ask whether the concurrent fourfold increase in work-from-home (WFH) rates caused this surge, or whether a tight post-pandemic labor market and shifting demographics are responsible. To isolate the causal effect of WFH, the authors clear three methodological hurdles. First, they restrict their sample to the five physical disability categories in the Current Population Survey (hearing, vision, ambulatory, self-care, and independent living), dropping the cognitive category entirely — its population grew by over a million during the pandemic, likely due to long COVID and anxiety, which would artificially inflate apparent employment gains. Second, they measure WFH rates using only non-disabled workers within each occupation, preventing reverse causality: individuals with disabilities make up roughly 3% of the workforce and cannot plausibly have driven a society-wide 400% shift in remote work adoption. Third, they exploit variation across 86 occupational codes — comparing high-WFH occupations like computer science against low-WFH ones like secondary teaching — while flexibly controlling for general employment growth within each occupation to strip out the effect of labor market tightness. The resulting causal estimate is a 1.0% increase in full-time disability employment for every 1 percentage point rise in WFH, strengthening to 1.3% when the authors use a pre-pandemic instrumental variable (the Dingel–Neiman remote-work feasibility index) that is entirely free of pandemic-era demand shocks. To determine *why*, the team examined wage data using a triple-difference model comparing disabled and non-disabled workers in the same remote-heavy occupations. Relative wages for disabled workers fell 4.2% — a textbook signature of an outward labor supply shift, not a demand shock. Workers previously locked out by commuting barriers and inaccessible office environments entered the market once those frictions disappeared, and their influx outpaced employer demand, pushing relative wages down even as employment climbed. **Three takeaways** 1. A 1 percentage point increase in WFH within an occupation causally increases full-time employment for physically disabled workers by 1.0–1.3%, depending on the estimation strategy. 2. The post-pandemic expansion of remote work accounts for 68–85% of the total rise in full-time employment for this demographic — ruling out labor market tightness as the primary driver. 3. A 4.2% relative wage decline for disabled workers in high-WFH occupations, alongside rising employment, is consistent with a labor supply expansion: WFH removed commuting and workplace accessibility barriers, drawing a large latent workforce into the market. **Read the source:** https://doi.org/10.1257/aeri.20240538

**Paper:** [From free speech advocates to critics: The Trump administration's new rhetoric promotes support for censorship among Trump voters](https://doi.org/10.1073/pnas.2532084123) **Authors:** Matthew E. K. Hall, B. Tyler Leigh, Brittany C. Solomon **Journal:** Proceedings of the National Academy of Sciences, 2026 **Why it matters:** The study offers rare experimental evidence — using real, not hypothetical, elite rhetoric — that partisan cues can meaningfully erode public commitment to one of the most widely endorsed democratic norms in the United States. --- **Summary** Following the assassination of conservative activist Charlie Kirk, the Trump administration's messaging shifted from championing free speech to explicitly endorsing restrictions on it — an unusual move for a sitting president. Researchers at the University of Notre Dame seized on this as a natural experimental stimulus and conducted a pre-registered survey experiment (meaning hypotheses, sample sizes, and statistical models were publicly locked in before any data were collected) with 13,305 quota-matched U.S. adults in October 2025. Participants were randomly assigned to read real anti-speech quotes from Trump and his allies, researcher-generated pro-speech quotes in a similar style, or no quotes at all, and their support for government censorship of out-party media and individuals was then measured. Among Trump voters exposed to the anti-speech rhetoric, support for censoring the opposing party increased significantly — a shift of roughly 0.35 on a standard scale, translating to approximately one in three respondents moving from opposition or neutrality toward acceptance of censorship. The researchers describe this migration toward indifference as "democratic neutrality," arguing that a norm does not require passionate authoritarians to collapse; it only requires enough people to stop actively defending it. The pro-speech control quotes, by contrast, produced no measurable effect in either direction, suggesting that confirming an existing baseline belief does not trigger the same cognitive reprocessing that a norm violation does. One particularly striking finding — and a key methodological strength — was that stripping Trump's name from the quotes and attributing them to a generic "prominent politician" produced identical results. The rhetoric moved attitudes at the same rate regardless of explicit attribution, indicating that the grievance framing and linguistic style had been sufficiently internalized to function as a partisan signal on their own. A notable caveat is that the study captures a short-term attitudinal snapshot; whether repeated exposure consolidates these shifts into durable opinion change remains an open question. --- **Three takeaways** 1. Exposure to explicit anti-speech rhetoric from Trump and his allies produced a statistically significant increase in support for government censorship of the out-party among Trump voters (β = 0.35), shifting roughly one in three toward a position of democratic neutrality. 2. The identical rhetoric had the opposite effect on non-Trump voters — Harris voters, third-party voters, and non-voters — who responded with a significant backlash, becoming meaningfully *more* protective of out-party speech. 3. The attitudinal shifts occurred at equivalent rates whether or not the quotes were attributed to Trump by name, demonstrating that the rhetorical style and grievance framing alone were sufficient to trigger partisan realignment without an explicit source label. --- **Read the source:** https://doi.org/10.1073/pnas.2532084123

**Monday Immune Engager** — our weekly pick from the latest immune-engager digest. **Paper:** [MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial](https://doi.org/10.1038/s41591-026-04455-x) **Authors:** Martin Wermke, Sebastian Ochsenreither, Dirk Jaeger, Heiko Becker, et al. **Journal:** Nature Medicine, 2025 **Why it matters:** By using an engineered T cell receptor domain instead of an antibody to target intracellular cancer-testis antigens presented on the cell surface via HLA, IMA401 opens a route to solid tumor immunotherapy that sidesteps the target-scarcity problem that has long limited bispecific T cell engagers in this setting. --- **Summary** Conventional bispecific T cell engagers (TCEs) are constrained to surface antigens, which are rarely tumor-specific enough in solid tumors to avoid on-target, off-tumor toxicity. IMA401 addresses this by replacing the antibody-based targeting arm with a high-affinity TCR domain that recognizes a peptide derived from the cancer-testis antigens MAGE-A4 and MAGE-A8 presented on the HLA-A\*02:01 allele — proteins that are epigenetically silenced in normal adult tissue but re-expressed across a broad range of solid tumors. The molecule also incorporates a deliberately low-affinity CD3-recruiting domain, which reduces peripheral T cell "sink" sequestration and limits hyperactivation-driven exhaustion, and a silenced Fc region that extends serum half-life to roughly 15–17 days, enabling biweekly dosing. This prespecified interim analysis of a phase 1 basket trial enrolled 61 heavily pretreated patients (median 3–4 prior lines) across more than 15 solid tumor indications, using a Bayesian logistic regression model to guide dose escalation from 0.0066 mg to 2.5 mg. The maximum tolerated dose was not reached per protocol, and the recommended phase 2 dose (RP2D) was set at 1–2 mg biweekly. At 2.5 mg, three of seven patients experienced dose-limiting grade 4 neutropenia; introducing 8 mg dexamethasone premedication with step dosing eliminated further dose-limiting toxicities within the RP2D range. Cytokine release syndrome occurred in 38% of patients but was exclusively grades 1–2, and no cases of immune effector cell-associated neurotoxicity syndrome (ICANS) were observed. One possibly treatment-related death from pneumonia occurred at 2.5 mg without dexamethasone premedication, in a patient with rapidly progressing lung metastases. In the RP2D-treated population (n = 41), the confirmed objective response rate (ORR) was 20%, rising to 29% in the largest histology subgroup — head and neck squamous cell carcinoma (4/14 patients) — with a 64% disease control rate and a median duration of response of 8.8 months. Objective responses were also observed in patients who had previously progressed on immune checkpoint inhibitors, including in a combination cohort with pembrolizumab that showed no additive toxicity. One melanoma patient maintained ongoing progression-free survival exceeding 33.9 months. --- **Three takeaways** 1. IMA401 demonstrated a 20% confirmed ORR at the RP2D across 15 tumor types, reaching 29% in head and neck squamous cell carcinoma — in patients with a median of 3–4 prior lines of therapy. 2. The safety profile at the RP2D was characterized by exclusively low-grade (grades 1–2) cytokine release syndrome, zero cases of ICANS, and a dose-dependent neutropenia that was clinically mitigated with dexamethasone premedication and step dosing. 3. Objective responses were observed in patients with prior immune checkpoint inhibitor resistance, and combining IMA401 with pembrolizumab produced no additive toxicity while maintaining antitumor activity. --- **Read the source:** https://doi.org/10.1038/s41591-026-04455-x

**Paper:** [Language Modeling Materializes a World Model of Protein Biology](https://biohub.ai/papers/esm_protein.pdf) **Authors:** Salvatore Candido, Alexander Rives, et al. **Journal:** White paper — Biohub / Evolutionary Scale **Why it matters:** Training a protein language model on billions of diverse metagenomic sequences appears to produce not just pattern matching but an internally organized, causally predictive representation of biophysical and functional principles — with direct implications for structure prediction and therapeutic design. --- **Summary** The paper asks whether scaling masked language modeling on protein sequences — where the model learns to predict missing amino acids from surrounding context — genuinely forces the emergence of a world model of protein biology, or merely produces sophisticated statistical memorization. The training corpus for the ESM Cambrian (ESMC) model family expands from the ~50 million sequences used in ESM2 to roughly 2.8 billion sequences, drawn heavily from metagenomic datasets including samples from hydrothermal vents, permafrost, and hypersaline lakes. Scaling compute up to a 6-billion-parameter model reveals a log-linear relationship between compute and precision in predicting long-range tertiary contacts — the physical touches between amino acids that are distant in the 1D sequence — with no observed plateau. Layer-level analysis of ESMC shows the network decouples enzymatic function (peaking around layers 50–60) from fine-grained 3D structural information (peaking in the final layers), and can recognize identical catalytic function across entirely different protein fold topologies. The companion structure prediction system, ESMFold 2, projects atomic coordinates directly from single-sequence representations using a stabilized recurrent architecture — looping pairwise state through the same weights up to 48 times with a contractive map to prevent exploding activations — achieving state-of-the-art results on FoldBench, particularly on antibody–antigen docking (scored by DockQ). Generative design experiments produced single-chain variable fragments binding clinically relevant targets like PD-L1 at nanomolar affinity. To interrogate the latent space, the researchers applied sparse autoencoders (SAEs) to layer 60 of ESMC, decomposing polysemantic dense embeddings into interpretable, higher-dimensional sparse features corresponding to secondary structures, taxonomic groups, and complex pathway memberships such as MitoCarta assignments. Using max-pooled SAE features as protein barcodes, remote homology retrieval outperformed both FoldSeek (structure-based) and MMseqs2 (sequence-based) at under 30% sequence identity. Two validation experiments — unsupervised clustering of over 2 million unannotated proteins and NMF-based pathway assignment to uncharacterized sequences — support the claim that these features reflect causal biological organization rather than label projection. --- **Three takeaways** 1. Scaling a masked protein language model on 2.8 billion metagenomic sequences produces a log-linear improvement in long-range contact prediction that shows no sign of plateauing at 6 billion parameters. 2. ESMFold 2's stabilized recurrent folding module achieves state-of-the-art DockQ performance on antibody–antigen complexes from single sequences, largely without relying on multiple sequence alignments. 3. Sparse autoencoder features extracted from ESMC layer 60 enable remote homology retrieval at below 30% sequence identity that outperforms both structural and sequence-alignment baselines, and successfully clusters over 2 million functionally unannotated proteins. --- **Read the source:** https://biohub.ai/papers/esm_protein.pdf

**Monday Immune Engager** — our weekly pick from the latest immune-engager digest. **Paper:** [Novel bispecific T-cell engagers overcoming acquired EGFR resistance](https://doi.org/10.1080/19420862.2026.2674236) **Authors:** Lennart Kühl, Ann-Kathrin Löffler, Oliver Seifert, Dennis Michler, et al. **Journal:** mAbs, 2026 **Why it matters:** Acquired resistance to EGFR-targeted antibody therapies remains a major barrier in colorectal and head-and-neck cancers, and this study presents an engineered antibody-based approach that circumvents both extracellular receptor mutations and downstream signaling bypass. --- **Summary** EGFR (epidermal growth factor receptor) is a well-validated oncology target, but monoclonal antibodies like cetuximab frequently lose efficacy as tumors acquire missense mutations — single amino acid substitutions such as S492R and G465R — in the extracellular domain where cetuximab binds. To find antibodies that could sidestep these escape variants, the researchers screened a human antibody phage display library against mutant EGFR protein, identifying an initial hit (A7) and then improving its binding roughly eightfold through VL shuffling (systematically swapping the antibody light chain while retaining the productive heavy chain), yielding the lead antibody H10 with a dissociation constant of ~4 nM. Epitope mapping confirmed that H10 binds a region overlapping but spatially shifted from the cetuximab site, explaining why it retains high affinity for the clinically prevalent escape variants that abolish cetuximab binding. Functional assays showed H10 suppresses EGFR phosphorylation, blocks downstream ERK signaling, and inhibits tumor cell proliferation comparably to cetuximab on wild-type-expressing cells. Because tumors can also acquire activating KRAS mutations that short-circuit EGFR signaling downstream — rendering surface blockade irrelevant — the team re-engineered H10 into bispecific T-cell engagers (TCEs) that physically recruit CD3-positive killer T cells to the tumor cell, bypassing intracellular resistance entirely. Two formats were tested: a 1+1 (one EGFR arm, one CD3 arm) and a 2+1 (two EGFR arms, one CD3 arm). The 2+1 format exploited avidity — a stronger, geometrically stable two-handed grip — and proved markedly superior on tumor cells expressing low levels of EGFR (~1,000 receptors/cell). In vitro co-culture assays demonstrated potent T cell–mediated killing of cells bearing S492R, G465R, and KRAS-mutant backgrounds where cetuximab-based TCEs completely failed, and a syngeneic mouse model showed significant tumor growth inhibition. A key limitation acknowledged by the authors is on-target/off-tumor toxicity: EGFR is expressed on healthy epithelial tissues, and broad T-cell activation risks cytokine release syndrome — a challenge the researchers note will likely require protease-activatable masking strategies in future clinical development. --- **Three takeaways** 1. H10 binds an epitope that overlaps with but is spatially shifted from the cetuximab binding site, enabling it to maintain high affinity for the major clinical escape variants S492R and G465R that completely abrogate cetuximab binding. 2. A 2+1 bispecific format — two EGFR-binding arms and one CD3-binding arm — leverages avidity to achieve potent T cell–mediated cytotoxicity even on tumor cells expressing as few as ~1,000 EGFR molecules per cell, where the 1+1 format was substantially less effective. 3. H10-based TCEs successfully killed tumor cells harboring both extracellular EGFR escape mutations and downstream KRAS activating mutations in vitro, and suppressed tumor growth in a syngeneic mouse model — resistance mechanisms that rendered cetuximab-based TCEs ineffective. --- **Read the paper:** [https://doi.org/10.1080/19420862.2026.2674236](https://doi.org/10.1080/19420862.2026.2674236)

**Paper:** [The lived experience of rejection sensitivity in ADHD — A qualitative exploration](https://doi.org/10.1371/journal.pone.0314669) **Authors:** Annabel Rowney-Smith, Beth Sutton, Lisa Quadt, Jessica A. Eccles **Journal:** PLOS One, 2024 **Why it matters:** Emotional dysregulation — and rejection sensitivity in particular — affects the majority of adults with ADHD yet remains largely absent from standard diagnostic criteria, leaving a significant dimension of patient suffering unrecognized and untreated. --- **Summary** Rejection sensitivity is a facet of emotional dysregulation in which perceived criticism or social rejection triggers intense dysphoria (profound psychological unease, from the Greek "hard to bear"). Despite emotional dysregulation being estimated to affect up to 70% of adults with ADHD, it is systematically excluded from mainstream diagnostic criteria, which have historically prioritized observable, externalizing behaviors like inattention and hyperactivity. To capture this hidden internal experience, the authors conducted semi-structured focus group interviews with five undergraduate students holding formal ADHD diagnoses, then applied thematic analysis to the transcripts. The open-ended prompt — "If you do, how do you identify with rejection-sensitive dysphoria?" — allowed participants to drive the narrative. Analysis revealed three core themes. First, **withdrawal**: participants described preemptive social and academic avoidance, including deliberately submitting university work late or below standard to create a psychological buffer against a professor's criticism — even when a 10% grade penalty was automatic. Second, **masking** (also called camouflaging): to avoid being labeled "needy," participants constructed a performed exterior of toughness so sustained that it produced dissociation — a state in which they felt like outside observers of their own conversations, disconnected from their authentic emotional states. Third, **bodily sensations**: perceived rejection triggered vivid physical responses — chest tightness, throat constriction, gastrointestinal nausea, and a spreading internal heat one participant compared to a chemical hand warmer — consistent with acute sympathetic nervous system (fight-or-flight) activation. The key limitation is sample size: only five participants, two of whom also carried an autism spectrum diagnosis and one a dyslexia diagnosis, making it impossible to isolate ADHD-specific mechanisms from co-occurring neurodivergent traits. The findings are a valuable starting point for a larger research agenda rather than generalizable conclusions. --- **Three takeaways** 1. Anticipatory fear of rejection — not confirmed rejection itself — was the primary driver of preemptive withdrawal, including deliberate academic self-sabotage that narrowed participants' long-term social and career trajectories. 2. Sustained masking backfired: projecting indifference caused peers to deliver harsher criticism, intensifying the very rejection sensitivity it was meant to conceal and producing a dissociative disconnection from participants' own emotional states. 3. Rejection sensitivity produced acute, individualized physical symptoms — spreading heat, cardiac awareness, nausea, and paralysis — that participants and the authors characterized as functionally identical to a fight-or-flight stress response. --- **Read the paper:** [https://doi.org/10.1371/journal.pone.0314669](https://doi.org/10.1371/journal.pone.0314669)

**Monday Immune Engager** — our weekly pick from the latest immune-engager digest. **Paper:** [Deep peptide recognition profiling decodes TCR specificity and enables disease-associated antigen discovery](https://doi.org/10.1038/s41587-026-03128-x) **Authors:** Nan Wang, Hugh Yeh, Ben Lai, Jason Perera, Kevin M. Jude, et al. **Journal:** Nature Biotechnology, 2026 **Why it matters:** Mapping how T cell receptors actually recognize peptides — rather than inferring it from sequence alone — opens a scalable path to identifying the self-antigens driving autoimmune diseases like ankylosing spondylitis. **Summary** Predicting what a T cell receptor (TCR) will recognize based on its amino acid sequence is notoriously unreliable: nearly identical TCRs can bind completely different antigens, while structurally dissimilar TCRs can converge on the same target. To attack this problem directly, the authors focused on a clinically defined set of HLA-B\*27:05-restricted TCRs from patients with ankylosing spondylitis (a disease causing spinal fusion) and acute anterior uveitis (severe inflammatory eye disease). They used high-throughput yeast display — engineering yeast to present roughly one billion peptides on their surfaces — to screen 21 patient-derived TCRs and generate what they call deep peptide recognition profiles (PRPs): empirical maps of which peptides each TCR actually binds. Because the HLA-B\*27:05 binding groove strongly favors arginine at position 2 and proline at position 8 as anchor residues, the team fixed those positions to stabilize the library and concentrate diversity in the central contact residues where the CDR3β loop — the dominant recognition element in this system — makes its contacts. The resulting PRPs were used to fine-tune protein language models (pLMs) built on a transformer encoder paired with a convolutional neural network. These models substantially outperformed AlphaFold3 and tFold-TCR at predicting T cell activation. Critically, functional clustering of TCRs by Jensen-Shannon divergence of their PRPs was largely independent of sequence similarity metrics like CDR3β edit distance and TCRdist — confirming that sequence proximity is a poor proxy for recognition overlap. Turning the trained models on the human proteome, the team identified novel candidate autoantigens, including a peptide derived from the gene *PSG5*, and validated it by showing that CD8⁺ T cells from HLA-B27-positive patients upregulated the activation marker CD69 in response to this peptide. An important caveat: fixing anchor residues creates a reductionist model of the natural peptide repertoire, and while CDR3β dominates in this system, the authors acknowledge that the alpha chain modulates response magnitude and could limit generalization to other HLA contexts. To address uncertainty when predicting novel TCRs, the authors introduced a Mahalanobis distance metric that quantifies how far a new TCR sits from the training distribution in the model's learned embedding space — effectively a built-in confidence score that flags when predictions should not be trusted and directs experimental resources toward functionally uncharted receptors. **Three takeaways** 1. TCR functional clustering based on PRP divergence (Jensen-Shannon distance) is largely independent of sequence similarity, demonstrating that CDR3β edit distance and TCRdist fail to capture convergent recognition in this system. 2. pLMs fine-tuned on PRPs outperform AlphaFold3 and tFold-TCR in predicting T cell activation, and this capability enabled the discovery and in vitro validation of *PSG5* as a novel candidate autoantigen recognized by patient-derived HLA-B27-positive CD8⁺ T cells. 3. Model generalization to held-out TCRs correlates with functional distance (PRP divergence) rather than sequence similarity, and Mahalanobis distance in the model's embedding space serves as a reliable intrinsic confidence metric to prioritize future experimental mapping. **Read the paper:** [https://doi.org/10.1038/s41587-026-03128-x](https://doi.org/10.1038/s41587-026-03128-x)

**Paper:** [The political polarization of health outcomes in the USA](https://doi.org/10.1038/s41562-026-02474-9) **Authors:** Elizabeth Elder, Neil A. O'Brian **Journal:** Nature Human Behaviour, 2026 **Why it matters:** Political ideology has emerged as a measurable social determinant of health in the United States, with conservative Americans showing widening gaps in both clinical biomarkers and mortality that persist after accounting for COVID-19, geography, and demographic change. --- **Summary** To move beyond the well-known limitations of county-level ecological data and subjective self-reports, Elder and O'Brian used individual-level longitudinal data from the Add Health cohort — the same participants tracked from adolescence in 1994 through adulthood — alongside CDC death records. They focused on Waves 4 and 5 of the survey (2008–2009 and 2016–2018), during which trained interviewers collected five objective clinical biomarkers in respondents' homes: BMI, lipid panels, HbA1c (a blood glucose marker), blood pressure, and C-reactive protein (a marker of systemic inflammation). These were combined into a single comorbidity index. In Wave 4, when participants were in their late 20s to early 30s, equivalence testing revealed no statistically significant health gap across the political spectrum. By Wave 5, the most conservative respondents had diverged significantly, with the gap representing roughly one-third of a standard deviation on the comorbidity index — an unusually large split for a relatively young cohort over less than a decade. To decompose the gap's origins, the authors applied a Kitagawa-Oaxaca-Blinder decomposition, which partitions a between-group difference into changes in observable characteristics versus unexplained factors. Approximately half of the widening was explained by socioeconomic sorting: individuals with higher education and income — strongly protective health endowments — increasingly aligned with the liberal coalition, while less healthy individuals shifted toward the conservative camp. Conservatives showed relative gains in marriage rates and religious community ties, both protective factors, but these were outweighed by the income and education effects. The remaining unexplained gap persisted into the mortality data: cross-referencing the cohort with the National Death Index through 2020–2022, very conservative respondents were 1.144 percentage points more likely to die of internal causes than very liberal respondents. Critically, this gap held after excluding COVID-19 deaths and after applying county fixed effects — meaning the disparity survived among liberals and conservatives living in the same local health jurisdiction. A large 2024 public opinion survey (the CHIP 50, n > 21,000) pointed toward a behavioral mechanism: right-leaning individuals reported substantially lower trust in primary care providers and emergency physicians, lower willingness to seek care for acute symptoms, and — among those with chronic conditions like hypertension or diabetes — greater skepticism about the safety and effectiveness of their own medications. --- **Three takeaways** 1. A comorbidity gap between conservative and liberal Americans was essentially absent in 2008–2009 but had grown to roughly one-third of a standard deviation by 2016–2018; Kitagawa-Oaxaca-Blinder decomposition attributes approximately half of this widening to socioeconomic sorting into political coalitions. 2. By the early 2020s, very conservative respondents faced a statistically significant elevation in non-COVID internal-cause mortality (heart disease, cancer, stroke) that was not explained by geographic location, local public health policy, demographic composition, or the COVID-19 pandemic. 3. Survey data from 2024 show that right-leaning individuals — measured by vote choice, partisanship, and ideological self-placement — are significantly less likely to seek care for acute cardiac symptoms and more likely to doubt the effectiveness of medications they are already taking for chronic conditions, suggesting declining medical trust as a partial behavioral driver of the mortality gap. --- **Read the paper:** [https://doi.org/10.1038/s41562-026-02474-9](https://doi.org/10.1038/s41562-026-02474-9)

**Paper:** [Enable CAR T cell immunotherapy in glioblastoma by modifying its microenvironment via oncolytic adenovirus encoding bispecific T cell engager](https://doi.org/10.1016/j.omton.2026.201201) **Authors:** Moon Jung Choi, Eui Young So, Bedia Akosman, Young Eun Lee, et al. **Journal:** Molecular Therapy Oncology, 2026 **Why it matters:** Glioblastoma has resisted every modern immunotherapy due to its physical and immunological defenses, and this study presents a multimodal platform that simultaneously addresses immune exclusion, antigen escape, and tumor heterogeneity. --- **Summary** Glioblastoma (GBM) remains one of the most treatment-resistant cancers, with median survival stubbornly anchored near 12–18 months despite maximal surgical resection, radiation, and temozolomide chemotherapy. CAR T cell therapies have shown only transient responses in clinical trials, stymied by two compounding problems: the blood-brain barrier (BBB) physically restricts immune cell trafficking into the tumor, and GBM's extreme antigen heterogeneity allows surviving cells to simply downregulate the targeted antigen and escape. To address this, the authors engineered a conditionally replicative oncolytic adenovirus — Ad5-Δ24-RGD, which carries a 24-base-pair deletion in its E1A gene preventing replication in cells with intact retinoblastoma (RB) tumor suppressor pathway — to act as a local factory, continuously producing a bispecific T cell engager (BiTE) that simultaneously binds CD3 on T cells and IL-13Rα2, an antigen highly specific to GBM. This "OV-BiTE" was then combined with intravenously infused CAR T cells dual-targeted to EGFR and EGFRvIII, creating a three-antigen crossfire against the tumor. In 3D GBM-BBB spheroid models incorporating astrocytes, endothelial cells, and pericytes, OV-BiTE treatment downregulated key endothelial tight junction proteins — Claudin-5, Occludin, and ZO-1 — measurably increasing barrier permeability and T cell infiltration compared to virus or controls alone. In a subcutaneous U87 GBM xenograft mouse model, sequential intratumoral OV-BiTE injection followed three days later by intravenous dual-targeted CAR T cell infusion produced markedly superior tumor regression versus any monotherapy arm, with histology confirming deep CD3+ T cell infiltration into the tumor core and significant reduction in IL-13Rα2-expressing cells. Importantly, mice tolerated the combination without body weight loss or overt toxicity signs. The critical caveat is that all in vivo efficacy data derives from a subcutaneous flank model rather than an intracranial orthotopic model, meaning true BBB dynamics, neuroinflammatory risk, and cerebral edema potential remain untested in a physiologically relevant CNS setting. --- **Three takeaways** 1. OV-BiTE infection actively downregulated endothelial tight junction proteins Claudin-5, Occludin, and ZO-1 in GBM-BBB spheroid models, significantly increasing the physical infiltration of circulating T cells across the barrier compared to untreated or virus-only controls. 2. Sequential intratumoral OV-BiTE followed by systemic dual-targeted EGFR/EGFRvIII CAR T cell infusion produced superior tumor regression and deeper intratumoral CD3+ T cell infiltration in a xenograft mouse model compared to either CAR T cell therapy or oncolytic virus alone. 3. Simultaneously targeting three distinct antigens — IL-13Rα2 via the virus-encoded BiTE, and EGFR/EGFRvIII via the CAR T cells — produced a multi-antigen crossfire that directly countered GBM's antigen escape mechanism, which monotherapy approaches consistently fail to overcome. --- **Read the paper:** [https://doi.org/10.1016/j.omton.2026.201201](https://doi.org/10.1016/j.omton.2026.201201)

**Paper:** [Climate-driven depopulation and adaptation realities in America's coastal ground zero](https://doi.org/10.1038/s41893-026-01820-z) **Authors:** Torbjörn E. Törnqvist, Brianna Castro, Jesse M. Keenan, Jayur M. Mehta, Zhixiong Shen **Journal:** Nature Sustainability, 2026 **Why it matters:** The central U.S. Gulf Coast — identified by the IPCC as the single most exposed low-elevation coastal zone globally this century — offers an empirical test case for how geology, archaeology, and demographics together constrain what climate adaptation can realistically achieve. **Summary** The paper asks a deceptively simple question: given what the physical record actually tells us about past sea levels, what is genuinely possible for coastal Louisiana going forward? The authors anchor their analysis in field evidence from the last interglacial period (LIG, ~125,000 years ago), when global temperatures were roughly 0.5–1.5 °C above pre-industrial values — a threshold modern warming is already approaching. They located the LIG shoreline at the Ponchitula Ridge, roughly 50 km north of present-day New Orleans. After correcting for tectonic subsidence driven by the Baton Rouge fault zone, the authors calculate that relative sea level (RSL) during the LIG stood at approximately +7.5 meters — implying a committed future RSL rise of 3–7 meters and a shoreline that could migrate up to 100 km inland. That geological baseline, they argue, makes long-term static coastal defense physically impossible, regardless of engineering ambition. The paper then layers in archaeological evidence showing that Native American communities in the delta successfully navigated this same geological instability through adaptive mobility — tracking deltaic lobe switching (avulsion), constructing elevated shell-midden platforms on natural levees, and migrating when landscapes degraded past a threshold. Modern land-tenure systems, fixed mortgages, and rigid zoning have replaced that mobility with what the authors call a "socio-ecological trap," in which adaptation measures like home elevation paradoxically deepen financial and psychological commitment to doomed coordinates. Present-day demographic data support this framing: the region is already experiencing a chaotic "pulse-retreat" pattern of outmigration, with Orleans Parish losing ~25% of its population since 2000 and rural Cameron Parish losing more than half, declines punctuated sharply by hurricanes Katrina, Rita, Laura, and Delta. The paper's most pointed policy argument concerns Louisiana's 2025 cancellation of two major sediment diversion projects — the only scientifically supported mechanism for large-scale, sustainable land building. The authors contend this decision eliminates the primary tool for buying time and forecloses the possibility of orderly, multi-generational managed relocation to higher Pleistocene terraces north of Lake Pontchartrain. A key limitation the authors acknowledge is that the exact timeline for committed sea-level rise remains uncertain; the geological evidence establishes physical capacity, not a precise delivery date. **Three takeaways** 1. Field evidence from the LIG shoreline, corrected for regional subsidence, places past RSL at +7.5 meters — committing the central Gulf Coast to 3–7 meters of future relative sea-level rise and potential shoreline retreat of up to 100 km inland. 2. Present-day outmigration follows a pulse-retreat pattern in which hurricane shocks trigger sharp, partially irreversible population drops; socioeconomic stressors — particularly collapsing property insurance markets — amplify environmental stress into financial displacement, distinguishing Louisiana's trajectory from Florida's continued coastal growth. 3. Louisiana's cancellation of large-scale sediment diversions in favor of organic marsh creation removes the only biophysically viable method of sustained land building, drastically compressing the window available for coordinated managed relocation and making chaotic, market-driven displacement the default outcome. **Read the paper:** [https://doi.org/10.1038/s41893-026-01820-z](https://doi.org/10.1038/s41893-026-01820-z)

**Paper:** [Impact of high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism: a prospective randomized controlled study](https://doi.org/10.1186/s12916-023-03180-3) **Authors:** Wei-Jie Chen, Chun-Xia Gan, Yang-Wei Cai, Yang-Yang Liu, et al. **Journal:** BMC Medicine, 2023 **Why it matters:** Even when catheter ablation successfully restores heart rhythm, microscopic clots can silently lodge in the brain — and this trial tests whether a next-generation cooling catheter actually reduces that hidden risk. --- **Summary** Catheter ablation for atrial fibrillation (AF) — where radiofrequency energy is used to scar the tissue driving abnormal electrical signals — is highly effective, but the heat applied to actively circulating blood can generate micro-emboli (tiny clots and gaseous particles) that travel to the brain. These "silent cerebral embolisms" (SCEs) produce no immediate symptoms yet show up as new lesions on sensitive imaging in a substantial fraction of patients. This trial asked whether a high-power short-duration (HPSD) strategy, delivering 50 W through a Smart Touch Surround Flow (STSF) catheter — which features 56 circumferential irrigation holes designed to aggressively cool the electrode-tissue interface — reduces SCE incidence compared to the conventional 30–35 W approach using a standard Smart Touch (ST) catheter. One hundred AF patients were randomized 1:1. High-resolution diffusion-weighted MRI (1 mm slice thickness on a 3.0 T scanner) was performed before and 24–72 hours after ablation to detect new lesions, with cognitive function assessed by the Montreal Cognitive Assessment (MoCA) at baseline, immediately post-procedure, and at three months. The HPSD technique was procedurally faster and required less irrigation fluid, confirming it delivered on its engineering promise. However, SCE rates were nearly identical: 44% in the HPSD group versus 40% in the conventional group (p = 0.685), with no significant differences in lesion count, maximum diameter, or total lesion volume. Multivariable regression identified persistent AF and a high CHA₂DS₂-VASc score (a validated stroke-risk metric) as the only independent predictors of SCE — not the catheter type or ablation duration. The finding suggests that sluggish, turbulent blood flow in a structurally remodeled, dilated left atrium overwhelms any cooling advantage the hardware provides. Reassuringly, patients who developed SCEs showed no detectable cognitive decline at three months compared to those with clean scans. A key limitation is the relatively small sample of 100 patients, which may have been underpowered to detect modest differences. --- **Three takeaways** 1. The HPSD/STSF approach produced SCEs in 44% of patients versus 40% with conventional ablation — a difference that was not statistically significant (p = 0.685), meaning the advanced cooling catheter conferred no measurable brain protection. 2. Multivariable regression showed that persistent AF and CHA₂DS₂-VASc score — markers of adverse cardiac remodeling and baseline thrombotic risk — were the only independent predictors of SCE, with catheter type and ablation duration eliminated as predictors. 3. Despite 106 new lesions detected across 42 patients (92% in the telencephalon), MoCA scores were stable at both the immediate post-procedure and three-month assessments, suggesting micro-lesions of this scale do not translate to detectable short-term cognitive decline. --- **Read the paper:** [https://doi.org/10.1186/s12916-023-03180-3](https://doi.org/10.1186/s12916-023-03180-3)